Allied Healthcare Products
AHPI
AHPI was delisted on the 2nd of February, 2023.
11 hedge funds and large institutions have $1.19M invested in Allied Healthcare Products in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
22% more funds holding
Funds holding: 9 → 11 (+2)
39% less capital invested
Capital invested by funds: $1.94M → $1.19M (-$755K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$54.2K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$36.5K |
| 3 |
Renaissance Technologies
New York
|
+$27.9K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.49K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.33K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$12K |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$353 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $623K | – | – | – |
|
|
2
Renaissance Technologies
New York
| $201K | +$27.9K | +7,900 | +14% |
|
|
3
Dimensional Fund Advisors
Austin,
Texas
| $143K | +$4.49K | +1,274 | +3% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $70K | – | – | – |
|
|
SSA
5
Schonfeld Strategic Advisors
New York
| $57K | -$353 | -100 | -0.6% |
|
|
6
Morgan Stanley
New York
| $50K | +$54.2K | +15,379 | +5,092% |
|
|
TSS
7
Two Sigma Securities
New York
| $33K | +$36.5K | +10,344 | New |
|
8
UBS Group
Zurich,
Switzerland
| $4K | +$4.3K | +1,220 | New |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $4K | +$4.33K | +1,228 | New |
|
|
10
Bank of America
Charlotte,
North Carolina
| – | -$12K | -2,111 | Closed |
|
AHPI Hedge Fund Activity: Q1 2022 in Review
11 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Allied Healthcare Products (AHPI) for Q1 2022, worth a combined $1.19M — down 39% from $1.94M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new AHPI positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $54.2K. The largest seller was Bank of America, exiting entirely with an estimated $12K sold.
- 11 institutional investors held Allied Healthcare Products (AHPI) as of Q1 2022, up from 9 in Q4 2021.
- Funds reported $1.19M of Allied Healthcare Products stock for Q1 2022, down 39% quarter-over-quarter.
- 3 funds opened new Allied Healthcare Products positions in Q1 2022 and 1 closed out, a net change of +2 holders.
- The largest Allied Healthcare Products buyer in Q1 2022 was Morgan Stanley, an estimated $54.2K added.
- The largest Allied Healthcare Products seller in Q1 2022 was Bank of America, an estimated $12K sold.
Based on aggregated 13F filings for Q1 2022.